Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic cancer increased by 1% from the previous year to 12%. The increase has generated more optimism from the Pancreatic Cancer Action Network (PanCAN), whose President and CEO Julie…
Insights From HumanFirst Show Breadth of Pharmaceutical Investment in AI/ML and Digital Endpoints in Clinical Trials
Regulators are increasingly approving AI-powered endpoints using digital health technologies (DHTs) in drug development. To quantify this trend, HumanFirst, life science’s first cloud-based platform for precision measures, today released an industry analysis showing just how many pharmaceutical sponsors have used…
Unlocking the Future of Drug Discovery with Artificial Intelligence
BCC’s newly released report, titled “Global Artificial Intelligence in Drug Discovery Market,” unveils the extraordinary impact of artificial intelligence (AI) on the pharmaceutical and biotech sectors. Authored by Ms. Surbhi Jagtap, Senior Analyst, this study provides invaluable insights into the…
Vial to Sponsor the 4th Annual Gene Therapy for Ophthalmic Disorders Conference 2023 in Boston, MA
Vial, a global full-service CRO providing tech-forward clinical trial management services, announced its participation as a sponsor and speaker at the 4th Annual Gene Therapy for Ophthalmic Disorders Conference in Boston, MA, October 3-5, 2023, at the Hilton Boston Back…
Ariceum Therapeutics doses first patient with its first-in-class targeted radiopharmaceutical drug satoreotide in its Phase Ib study in small cell lung cancer
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, is pleased to announce that the first patient has been dosed with its first-in-class lead molecule, satoreotide, targeting extensive stage small…
Beactica Therapeutics announces the selection of BEA-17 as a preclinical candidate
Beactica Therapeutics AB, the Swedish precision oncology company, today announced the selection of BEA-17 as a preclinical candidate for its LSD1 programme aimed at finding new therapies for aggressive brain tumours and other life-threatening cancers. BEA-17 is a first-in-class small…
National University Health System Launches World’s First Public Hospital’s Healthy Longevity Clinic at Alexandra Hospital
The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine and Alexandra Hospital (AH) have achieved a milestone by unveiling the world’s inaugural Healthy Longevity Clinic by public healthcare. Located at Singapore’s Alexandra Hospital, the clinic aims…
Getinge Deepens Commitment to Healthcare Access and Scalability in India
Getinge, a worldwide medtech innovator, is set to amplify its impact on the Indian market through the utilization of its India Innovation Centre (IIC) and by cultivating synergistic relationships with industry and academia, addressing a global market. The company holds…
